ESTRO 2024 - Abstract Book

S667

Clinical - Breast

ESTRO 2024

Conclusion:

At present hypofractionated WBI is the standard of care. However there is still a lack of literature data regarding sequential HB administration Our data show that 3DCRT hypofractionated WBI with a sequential HB is safe and well tolerated. In our series all reported late toxicities were G1 and resulted quite low even after a long-term follow-up.

Keywords: Breast cancer, Hypofractionated RT, Late toxicity

References:

1 Palumbo I, Mariucci C, Falcinelli L, Perrucci E, Lancellotta V, Podlesko AM, Marcantonini M, Saldi S, Bini V, Aristei C. Hypofractionated whole breast radiotherapy with or without hypofractionated boost in early stage breast cancer patients: a mono-institutional analysis of skin and subcutaneous toxicity. Breast Cancer. 2019 May;26(3):290-304. doi: 10.1007/s12282-018-0923-z